| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.5M | +53.3% |
| SG&A Expense | $1.4M | +28.3% |
| Operating Income | -$5.2M | -19.3% |
| Pre-tax Income | -$5.8M | -61.9% |
| Net Income | -$5.8M | -61.9% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $639K | -81.6% |
| Total Assets | $663K | -80.9% |
| Current Liabilities | $907K | +205.2% |
| Total Liabilities | $1.0M | +240.9% |
| Stockholders' Equity | -$368K | -111.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -16.1% |
| Capital Expenditures | $26K | — |
| Investing Cash Flow | -$26K | -243.9% |
| Financing Cash Flow | $4.7M | +0.0% |
| Free Cash Flow | -$2.8M | — |